ENTITY

OBI Pharma Inc (4174 TT)

6

Analysis

Health Care • Taiwan

OBI Pharma Inc manufactures anti-infective and immunotherapy drugs and develops cancer and infectious disease therapies.

more

Refresh

Exchange Announcement • 23 Dec 2024 14:30

Obi Pharma And Glytech Have Entered Into A Glycobi Marketing Agreement In Japan And A Material Transfer Agreement

Exchange Announcement • 10 Dec 2024 18:32

Announcement On Behalf Of Obigen To Acquire The Worldwide Intellectual Property Rights Of Obi-858 And Sign The Technology Transfer Agreement

Exchange Announcement • 10 Dec 2024 18:31

Obi’S Bod Resolved To Transfer The Worldwide Intellectual Property Rights Of Obi-858 And Sign The Technology Transfer Agreement

Exchange Announcement • 10 Dec 2024 18:25

The Company’S Bod Resolved The Redemption And Cancellation Of The Restricted Stock Awards And The Record Date Of Capital Reduction

Exchange Announcement • 06 Dec 2024 17:16

Announcement Of The Expiration Of The Company'S 2024 Cash Capital Increase Call Period And The Issuance Of Stocks

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x